Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison
Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endosc...
Saved in:
Published in | International forum of allergy & rhinology Vol. 12; no. 6; pp. 838 - 848 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear.
Methods
We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups.
Results
The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively).
Conclusion
The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients. |
---|---|
AbstractList | The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear.
We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well-balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment-related complications were compared between the 2 groups.
The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow-up of 15 (range, 2-63) months, the 2-year overall survival and progression-free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment-related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively).
The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment-related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients. BACKGROUNDThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. METHODSWe enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well-balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment-related complications were compared between the 2 groups. RESULTSThe cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow-up of 15 (range, 2-63) months, the 2-year overall survival and progression-free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment-related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). CONCLUSIONThe innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment-related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients. Abstract Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group ( p = 0.001, p = 0.014, and p = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients. Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients. |
Author | Wang, Huan Yu, Hongmeng Li, Wanpeng Zhang, Huangkang Sun, Xicai Dai, Jiong Liu, Quan Liu, Qiang Hu, Li Wang, Dehui Li, Houyong |
Author_xml | – sequence: 1 givenname: Wanpeng surname: Li fullname: Li, Wanpeng organization: Fudan University – sequence: 2 givenname: Qiang surname: Liu fullname: Liu, Qiang organization: Fudan University – sequence: 3 givenname: Huan surname: Wang fullname: Wang, Huan organization: Fudan University – sequence: 4 givenname: Huangkang surname: Zhang fullname: Zhang, Huangkang organization: Fudan University – sequence: 5 givenname: Quan surname: Liu fullname: Liu, Quan organization: Fudan University – sequence: 6 givenname: Li surname: Hu fullname: Hu, Li organization: Fudan University – sequence: 7 givenname: Houyong surname: Li fullname: Li, Houyong organization: Fudan University – sequence: 8 givenname: Jiong surname: Dai fullname: Dai, Jiong organization: Shanghai Jiaotong University School of Medicine – sequence: 9 givenname: Xicai surname: Sun fullname: Sun, Xicai email: laryngeal@163.com organization: Fudan University – sequence: 10 givenname: Hongmeng surname: Yu fullname: Yu, Hongmeng email: hongmengyush@163.com organization: Chinese Academy of Medical Sciences – sequence: 11 givenname: Dehui orcidid: 0000-0003-0346-3193 surname: Wang fullname: Wang, Dehui email: wangdehuient@sina.com organization: Fudan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34773719$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9qFTEUxoNUbK1d-AIScKOL207-T9xdStXCBaHoesjkT5uSScZk5sp15SP0OXwsn8S00xYUms13TvLjO5x8L8FeTNEC8Bo1x6hp8IkK-RhjicUzcIAbildctnTvsRZ8HxyVct3UwxBjSLwA-4QKQQSSB-D3eYxpqya_tVCNY_C61inC5KCPk81RBahVTpM3UOV6sYN26FPwPxfOR1hU2KpLC200qeg0eg2jKmm8UnkXL62e0rCDLmWYrZ5ztnH6530ZoH1Mg_oA17Up9s-vm0FN-soaqNMwquxLiq_Ac6dCsUf3egi-fTz7evp5tfny6fx0vVlpwohYcUxIL3mPMKbMcYawky1Xoq1CVE_r2s453IqWit4Yh4zkFAtOTIMMRQ05BO8W3zGn77MtUzf4om0IKto0lw4zKahEVMiKvv0PvU7z7Z9VinNCOWMtrtT7hdI5lZKt68bsh7p9h5ruNsOuZtjdZVjZN_eOcz9Y80g-JFaBkwX44YPdPe3UrTcXi-VfmSGr6A |
CitedBy_id | crossref_primary_10_1002_alr_22981 crossref_primary_10_1186_s12885_023_11760_y crossref_primary_10_1016_j_cson_2023_100018 crossref_primary_10_1002_alr_22979 crossref_primary_10_1002_hed_27244 crossref_primary_10_1002_alr_23051 crossref_primary_10_2147_CMAR_S409091 crossref_primary_10_1002_adfm_202209413 |
Cites_doi | 10.1007/s11912-020-00949-0 10.1016/j.ijrobp.2010.03.024 10.1177/1945892420964054 10.1007/s00270-005-0367-7 10.3389/fonc.2020.00437 10.3322/caac.21492 10.1016/j.amjoto.2020.102860 10.1038/s41571-021-00524-x 10.1007/s10147-017-1143-9 10.1177/0194599815616799 10.3389/fonc.2021.674889 10.3171/jns.1974.41.2.0125 10.1093/neuros/nyx075 10.1002/hed.24234 10.1016/S1470-2045(20)30673-2 10.1016/j.oraloncology.2020.104922 10.3389/fonc.2021.716729 10.1002/hed.20161 10.1097/00005537-200003000-00010 10.3171/2012.9.JNS12332 |
ContentType | Journal Article |
Copyright | 2021 ARS‐AAOA, LLC. 2021 ARS-AAOA, LLC. 2022 ARS‐AAOA, LLC. |
Copyright_xml | – notice: 2021 ARS‐AAOA, LLC. – notice: 2021 ARS-AAOA, LLC. – notice: 2022 ARS‐AAOA, LLC. |
DBID | NPM AAYXX CITATION K9. 7X8 |
DOI | 10.1002/alr.22927 |
DatabaseName | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2042-6984 |
EndPage | 848 |
ExternalDocumentID | 10_1002_alr_22927 34773719 ALR22927 |
Genre | article Journal Article |
GroupedDBID | --- 05W 0R~ 1OC 31~ 33P 4.4 50Y 52T 52V 53G 7PT 8-0 8-1 A00 AAESR AAHHS AANLZ AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI D-A DCZOG DRFUL DRMAN DRSTM EBD EBS EJD FEDTE FUBAC G-S GODZA HGLYW HVGLF HZ~ KBYEO LATKE LEEKS LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY. MY~ O9- OVD P2W P4E PQQKQ ROL RX1 SUPJJ TEORI WBKPD WOHZO WXSBR WYJ ZZTAW NPM AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c3537-6233b96b12245f6512f986a78f983ab4719fff287847bddf1d9642763d01d4103 |
ISSN | 2042-6976 |
IngestDate | Fri Aug 16 06:08:50 EDT 2024 Thu Oct 10 17:45:11 EDT 2024 Fri Aug 23 01:33:27 EDT 2024 Wed Oct 16 00:40:34 EDT 2024 Sat Aug 24 00:59:41 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | recurrent nasopharyngeal carcinoma internal carotid artery salvage surgery embolization survival |
Language | English |
License | 2021 ARS-AAOA, LLC. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3537-6233b96b12245f6512f986a78f983ab4719fff287847bddf1d9642763d01d4103 |
Notes | Additional Supporting Information may be found in the online version of this article. Wanpeng Li and Qiang Liu contributed equally to this work. Potential conflict of interest: None provided. View this article online at wileyonlinelibrary.com. Funding sources for the study: National Natural Science Foundation of China (No. 81870703); Shanghai Shen Kang Hospital Development Center (SHDC12018118); Clinical Research Plan of the SHDC (SHDC2020CR2005A); Shanghai Science and Technology Committee Foundation (19411950600); New Technologies of Endoscopic Surgery in Skull Base Tumor, CAMS innovation Fund for Medical Sciences (2019‐12 M‐5‐003); Science and Technology Commission of Shanghai Municipality (20Y11902000, 21ZR1411700); Shanghai Municipal Health Commission (201940143). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0346-3193 |
PMID | 34773719 |
PQID | 2663465582 |
PQPubID | 996378 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2597491479 proquest_journals_2663465582 crossref_primary_10_1002_alr_22927 pubmed_primary_34773719 wiley_primary_10_1002_alr_22927_ALR22927 |
PublicationCentury | 2000 |
PublicationDate | June 2022 2022-Jun 2022-06-00 20220601 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: June 2022 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | International forum of allergy & rhinology |
PublicationTitleAlternate | Int Forum Allergy Rhinol |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 35 2021; 42 2021; 22 2021; 11 2017; 81 1974; 41 2011; 80 2021; 18 2017; 22 2013; 118 2006; 29 2016; 154 2020; 111 2000; 110 1994; 15 2020; 22 2020; 10 2005; 26 2005; 27 2016; 38 2018; 68 Abud DG (e_1_2_6_15_1) 2005; 26 e_1_2_6_10_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_19_1 e_1_2_6_5_1 e_1_2_6_4_1 Linskey ME (e_1_2_6_21_1) 1994; 15 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_22_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_16_1 |
References_xml | – volume: 26 start-page: 2602 year: 2005 end-page: 2609 article-title: Venous phase timing during balloon test occlusion as a criterion for permanent internal carotid artery sacrifice publication-title: AJNR Am J Neuroradiol – volume: 68 start-page: 394 year: 2018 end-page: 424 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 80 start-page: 661 year: 2011 end-page: 668 article-title: How does intensity‐modulated radiotherapy versus conventional two‐dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? publication-title: Int J Radiat Oncol Biol Phys – volume: 81 start-page: 672 year: 2017 end-page: 679 article-title: Graft occlusion and graft size changes in complex internal carotid artery aneurysm treated by extracranial to intracranial bypass using high‐flow grafts with therapeutic internal carotid artery occlusion publication-title: Neurosurgery – volume: 22 start-page: 834 year: 2017 end-page: 842 article-title: Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10‐year experience publication-title: Int J Clin Oncol – volume: 29 start-page: 958 year: 2006 end-page: 968 article-title: Covered stent‐graft treatment of traumatic internal carotid artery pseudoaneurysms: a review publication-title: Cardiovasc Intervent Radiol – volume: 15 start-page: 829 year: 1994 end-page: 843 article-title: Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon‐enhanced CT publication-title: AJNR Am J Neuroradiol – volume: 27 start-page: 397 year: 2005 end-page: 405 article-title: Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group publication-title: Head Neck – volume: 10 start-page: 437 year: 2020 article-title: Quality of life following salvage endoscopic nasopharyngectomy in patients with recurrent nasopharyngeal carcinoma: a prospective study publication-title: Front Oncol – volume: 35 start-page: 458 year: 2021 end-page: 466 article-title: Salvage endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: prognostic factors and treatment outcomes publication-title: Am J Rhinol Allergy – volume: 111 year: 2020 article-title: A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery publication-title: Oral Oncol – volume: 154 start-page: 377 year: 2016 end-page: 382 article-title: Eustachian tube as a landmark to the internal carotid artery in endoscopic skull base surgery publication-title: Otolaryngol Head Neck Surg – volume: 41 start-page: 125 year: 1974 end-page: 145 article-title: Balloon catheterization and occlusion of major cerebral vessels publication-title: J Neurosurg – volume: 38 start-page: E1404 issue: 1 year: 2016 end-page: 1412 article-title: Extracranial/intracranial vascular bypass and craniofacial resection: new hope for patients with locally advanced recurrent nasopharyngeal carcinoma publication-title: Head Neck – volume: 42 year: 2021 article-title: Clinical efficacy of bypass grafting in recurrent nasopharyngeal carcinoma patients with internal carotid artery invasion publication-title: Am J Otolaryngol – volume: 22 start-page: 86 year: 2020 article-title: The management of rNPC: salvage surgery vs. re‐irradiation publication-title: Curr Oncol Rep – volume: 110 start-page: 386 year: 2000 end-page: 390 article-title: Assessment of carotid artery invasion in patients with head and neck cancer publication-title: Laryngoscope – volume: 22 start-page: 381 year: 2021 end-page: 390 article-title: Endoscopic surgery compared with intensity‐modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open‐label, randomised, controlled, phase 3 trial publication-title: Lancet Oncol – volume: 118 start-page: 637 year: 2013 end-page: 642 article-title: Cerebral revascularization and carotid artery resection at the skull base for treatment of advanced head and neck malignancies publication-title: J Neurosurg – volume: 11 year: 2021 article-title: Clinical outcomes of salvage endoscopic nasopharyngectomy for patients with advanced recurrent nasopharyngeal carcinoma publication-title: Front Oncol – volume: 11 year: 2021 article-title: Balloon test occlusion of internal carotid artery in recurrent nasopharyngeal carcinoma before endoscopic nasopharyngectomy: a single center experience publication-title: Front Oncol – volume: 18 start-page: 679 year: 2021 end-page: 695 article-title: Nasopharyngeal carcinoma: an evolving paradigm publication-title: Nat Rev Clin Oncol – ident: e_1_2_6_6_1 doi: 10.1007/s11912-020-00949-0 – volume: 15 start-page: 829 year: 1994 ident: e_1_2_6_21_1 article-title: Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon‐enhanced CT publication-title: AJNR Am J Neuroradiol contributor: fullname: Linskey ME – ident: e_1_2_6_5_1 doi: 10.1016/j.ijrobp.2010.03.024 – ident: e_1_2_6_7_1 doi: 10.1177/1945892420964054 – ident: e_1_2_6_18_1 doi: 10.1007/s00270-005-0367-7 – ident: e_1_2_6_8_1 doi: 10.3389/fonc.2020.00437 – ident: e_1_2_6_2_1 doi: 10.3322/caac.21492 – ident: e_1_2_6_23_1 doi: 10.1016/j.amjoto.2020.102860 – ident: e_1_2_6_3_1 doi: 10.1038/s41571-021-00524-x – ident: e_1_2_6_11_1 doi: 10.1007/s10147-017-1143-9 – ident: e_1_2_6_13_1 doi: 10.1177/0194599815616799 – ident: e_1_2_6_17_1 doi: 10.3389/fonc.2021.674889 – ident: e_1_2_6_16_1 doi: 10.3171/jns.1974.41.2.0125 – ident: e_1_2_6_19_1 doi: 10.1093/neuros/nyx075 – ident: e_1_2_6_22_1 doi: 10.1002/hed.24234 – ident: e_1_2_6_10_1 doi: 10.1016/S1470-2045(20)30673-2 – ident: e_1_2_6_9_1 doi: 10.1016/j.oraloncology.2020.104922 – ident: e_1_2_6_14_1 doi: 10.3389/fonc.2021.716729 – volume: 26 start-page: 2602 year: 2005 ident: e_1_2_6_15_1 article-title: Venous phase timing during balloon test occlusion as a criterion for permanent internal carotid artery sacrifice publication-title: AJNR Am J Neuroradiol contributor: fullname: Abud DG – ident: e_1_2_6_4_1 doi: 10.1002/hed.20161 – ident: e_1_2_6_12_1 doi: 10.1097/00005537-200003000-00010 – ident: e_1_2_6_20_1 doi: 10.3171/2012.9.JNS12332 |
SSID | ssj0000515517 |
Score | 2.3664043 |
Snippet | Background
The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients... The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors... Abstract Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC)... BackgroundThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients... BACKGROUNDThe efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 838 |
SubjectTerms | Carotid arteries Carotid artery Embolization Endoscopy Hemorrhage internal carotid artery Medical prognosis Nasopharyngeal carcinoma Patients recurrent nasopharyngeal carcinoma salvage surgery Surgery Survival Throat cancer Tumors |
Title | Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falr.22927 https://www.ncbi.nlm.nih.gov/pubmed/34773719 https://www.proquest.com/docview/2663465582 https://search.proquest.com/docview/2597491479 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHcKAxnEA1LV0djNxbx1wDTQhgTatL1FdpyUijaZunbSeOIn8Dv4VYhfwjm24yYUpMFLGp0kdaPz9dx8LoQ8i5kCtREO-oIBG4YiDvpyIJN-EoZax-CwhAKrkQ_eR3tHw3cn4Umn86ORtbRcqO3syx_rSv6Hq0ADvmKV7D9w1n8pEOAc-AtH4DAcL8Xjt26k6Xnea2xE110gjKGJY3kWE90zqZsXvXymqqkrvcRQx5mcnmPWTl7qCgtUJlmvlDjZQM4vyjFG9Gc2o3OOcXnTyal53S6QTcpqJm2NewZa0SdQgDUMmNAu0R3zlpq2cDsYabpCmKwELE4c20Se-adJO-6_b5IPjmV5mjuVa4hLpH4ApHvasYuD7y1X8PfBcSSOP9d3u5gHuMs-N8uKRoZFRZGIXRPtJs0OnPOynTUw3BTUie0pU-t82-1zTZ3Y9rRyOt9mTNgeBu2W3b-pUp_gaJtBsxQeTc2jV8gmA1EIMnhztPN6Z9fHAe2MHazq9y9VN8AasBd-6bbZtOYLtV0rYxsd3iDXnVNDRxahN0knL2-RqwcubeM2-b4CKm0AlVYFrYFKHVCpBSptAhVuog6odAVUugZUChiiHqi0DVTqgfqSjijC9OfXbw6gdAXQO-Ro983hq72-GxLSz3iIJa6McyUihTvEYRGB_VqIJJJxAh9cKrC9RFEULInBDFNaF4EW4HKDVtWDQA-DAb9LNsqqzO8TKjmX4NBEimdg5yomAwkOd8gjFXJdJKJLntY8SE9tL5h0jdFdslVzJ3Wi4iwFK5hjo8KEdckTfxkEOe7OyTKvlnAPuvYiGMawzj3LVb8KH8YxhzfpkueGzX9fPh3tfzQnDy7zYx-Sa6u_1xbZWMyX-SMwshfqscPpL-J02oU |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innovative+application+of+internal+carotid+artery+embolization+in+salvage+endoscopic+nasopharyngectomy+for+recurrent+nasopharyngeal+carcinoma%3A+A+case%E2%80%90matched+comparison&rft.jtitle=International+forum+of+allergy+%26+rhinology&rft.au=Li%2C+Wanpeng&rft.au=Liu%2C+Qiang&rft.au=Wang%2C+Huan&rft.au=Zhang%2C+Huangkang&rft.date=2022-06-01&rft.issn=2042-6976&rft.eissn=2042-6984&rft.volume=12&rft.issue=6&rft.spage=838&rft.epage=848&rft_id=info:doi/10.1002%2Falr.22927&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_alr_22927 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6976&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6976&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6976&client=summon |